Bioequivalence study of 300 mg irbesartan film-coated tablets preparations in healthy Thai volunteers

Authors

Porranee Puranajoti
Peerawong Werarak
Burapat Intawong
Jarunee Hongrapipat
Rungrudee Talubsri
Soravee Sangsuriyawong
Temsiri Kuamsuk

Abstract

Irbesartan, an angiotensin II receptor antagonist, is indicated for the treatment of essential hypertension alone or in combination with other antihypertensive agents. The purpose of this study was to compare the bioavailability of two formulations of ir...

Publisher

Faculty of Pharmaceutical Sciences, Chulalongkorn University

First Page

186

Last Page

193

Recommended Citation

Puranajoti, Porranee; Werarak, Peerawong; Intawong, Burapat; Hongrapipat, Jarunee; Talubsri, Rungrudee; Sangsuriyawong, Soravee; and Kuamsuk, Temsiri (2013) "Bioequivalence study of 300 mg irbesartan film-coated tablets preparations in healthy Thai volunteers," The Thai Journal of Pharmaceutical Sciences: Vol. 37: Iss. 4, Article 3.
Available at: https://digital.car.chula.ac.th/tjps/vol37/iss4/3